SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $973,000 | -38.4% | 19,321 | -26.8% | 0.05% | -44.2% |
| Q2 2018 | $1,579,000 | -52.1% | 26,389 | -63.3% | 0.10% | -60.1% |
| Q1 2018 | $3,297,000 | -43.5% | 71,989 | -50.8% | 0.24% | -48.1% |
| Q4 2017 | $5,834,000 | +22.8% | 146,396 | +23.2% | 0.46% | +15.9% |
| Q3 2017 | $4,751,000 | -7.3% | 118,782 | -0.1% | 0.40% | -16.1% |
| Q2 2017 | $5,125,000 | -14.2% | 118,907 | -37.7% | 0.47% | -21.3% |
| Q1 2017 | $5,976,000 | -66.7% | 190,938 | -73.2% | 0.60% | -2.8% |
| Q4 2016 | $17,968,000 | -10.0% | 711,599 | -11.8% | 0.62% | -5.7% |
| Q3 2016 | $19,958,000 | +13.8% | 807,049 | -6.3% | 0.65% | +2.3% |
| Q2 2016 | $17,538,000 | +195.0% | 860,969 | +120.9% | 0.64% | +195.8% |
| Q1 2016 | $5,945,000 | – | 389,840 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |